2004

Dec 15, 2004
Johnson & Johnson and Guidant Announce Definitive Agreement Valued at $23.9 Billion Based on $76 per Share

Transaction will bring together cardiovascular expertise and technologies to benefit patients and physicians worldwide New Brunswick, N.J. and Indianapolis, Ind. - Johnson & Johnson (NYSE: JNJ),...

Dec 1, 2004
Guidant Provides Mid-Quarter Update

Company Reiterates Guidance for the Fourth Quarter 2004, Full-Year 2004 and 2005 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today provided a mid-quarter update reiterating financial...

Nov 12, 2004
Guidant to Participate in Credit Suisse First Boston Annual Healthcare Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Nov 12, 2004
Guidant to Participate in the Merrill Lynch Medical Technology Fundamentals Conference

Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...

Oct 21, 2004
Guidant Begins Enrollment in New Study of Carotid Stenting

CAPTURE Will Advance Understanding of Carotid Stenting In High-Risk Patients at 150 U.S. Sites Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that the company has begun...

Show 5102550100 per page
Top